<DOC>
	<DOCNO>NCT03036293</DOCNO>
	<brief_summary>The purpose study : - To examine efficacy safety Tenoten® treatment anxiety patient somatoform , stress-related neurotic disorder . - To compare efficacy two dosing regimen Tenoten® ( 4 tablet daily vs.8 tablet daily , 12 week ) treatment anxiety patient somatoform , stress-related neurotic disorder .</brief_summary>
	<brief_title>Clinical Trial Tenoten® Treatment Anxiety Patients With Somatoform , Stress-related Other Neurotic Disorders</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Neurotic Disorders</mesh_term>
	<criteria>1 . Patients sex age 1845 year inclusively . 2 . Patients diagnose somatoform , stressrelated , neurotic disorder ( F43 , F45 , F48 ) , accordance ICD10 criterion . 3 . A moderate severe anxiety ( HADS score ≥ 11 ) document screen . 4 . Patients provide sign Informed Consent form participation clinical trial . 5 . Patients reproductive age ( sex ) use contraceptive contraceptive method study 30 day end participation trial . 1 . Moderate severe depression symptom record screening ( HADS score ≥ 11 ) . 2 . Organic , include symptomatic , mental disorder ( F0009 ) . 3 . Mental behavioural disorder due psychoactive substance use ( F1019 ) . 4 . Schizophrenia , schizotypal delusional disorder ( F2029 ) . 5 . Mood [ affective ] disorder ( F3039 ) . 6 . Phobic ( F40 ) anxiety disorder ( F41 ) , obsessivecompulsive disorder ( F42 ) , dissociative [ conversion ] disorder ( F44 ) , depersonalizationderealization syndrome ( F48.1 ) . 7 . Behavioral syndrome associate physiological disturbance physical factor ( F5059 ) . 8 . Disorders adult personality behavior ( F6069 ) . 9 . Intellectual disability ( F7079 ) . 10 . Inflammatory traumatic brain injury permanent neurological deficit . 11 . Prior diagnosis class III IV cardiovascular disease ( accord New York Heart Association , 1964 ) 12 . Malignant neoplasms/suspected malignant neoplasm . 13 . An allergy/intolerance component medication use treatment . 14 . Malabsorption syndrome ( include hereditary acquire lactase disaccharidase deficiency ) galactosemia . 15 . Any condition , investigator 's point view , may affect patient 's ability participate trial . 16 . Hospitalizations surgery schedule date participation study . 17 . Patients , investigator 's point view , fail comply observation requirement trial dose regimen study drug . 18 . Use drug list `` Prohibited drug '' within month prior enrollment . 19 . Drug addiction , alcohol use amount 2 unit alcohol day . 20 . Pregnant breastfeed woman . 21 . Participation clinical trial within 3 month prior enrollment study . 22 . Patients related research personnel investigative site directly involved trial , patient immediate family member researcher . The 'immediate family member ' include husband/wife , parent , child brother ( sister ) , regardless whether natural adopt . 23 . Patients work OOO `` NPF `` MATERIA MEDICA HOLDING '' , i.e . company 's employee , temporary contract worker , appoint official responsible carry research ( immediate relative ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>